Budget 2018-19

  Covid-19 vaccines for younger children and booster shots for at least those over 65 years old are being prepared in accordance with a tight schedule in the US Covid-19 vaccines for younger children and booster shots for at least those over 65 years old are being prepared in accordance with a tight schedule in the US, as the Americans stagger into the 19th month of their fierce battle against the pandemic. A lower dose of the  Pfizer-BioNTech  coronavirus vaccine, one-third the amount given to adults and teens, is safe and triggered a robust immune response in children as young as five years old, the drug companies announced in a news release on Monday morning. “The finding, eagerly anticipated by many parents and paediatricians, is a crucial step toward the two-shot coronavirus vaccine regimen becoming available for younger school-aged children, perhaps close to Halloween,” Xinhua news agency quoted The Washington Post as saying on Monday. However, the companies must pr...

  The European Commission will sign a deal to secure up to 300 million doses of the experimental coronavirus vaccine developed by BioNTech and Pfizer The European Commission will sign a deal to secure up to 300 million doses of the experimental coronavirus vaccine developed by BioNTech and Pfizer. Ursula von der Leyen, the president of the EU’s executive arm, said the commission will authorize the deal on Wednesday after working tirelessly to secure doses of potential vaccines in recent months. This is the most promising vaccine so far, von der Leyen said. Once this vaccine becomes available, our plan is to deploy it quickly, everywhere in Europe. Pfizer said Monday that early results from the vaccine suggests the shots may be a surprisingly robust 90% effective at preventing COVID-19. The European Commission had already secured three other deals with pharmaceutical companies allowing its 27 member states to buy nearly one billion doses of a potential  coronavirus vaccine. And...